Skip to main content
SpringerLink
Log in

Erlaubt eine Bestimmung von FGF23 bei chronisch nierenkranken Menschen eine verbesserte Vorhersage renaler und kardiovaskulärer Ereignisse?

Does a determination of FGF23 in chronic kidney disease allow improved prediction of renal and cardiovascular events?

  • Für Sie gelesen
  • Published:
Der Nephrologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Edmonston D, Wolf M (2019) FGF23 at the crossroads of phosphate, iron economy and erythropoiesis. Nat Rev Nephrol. https://doi.org/10.1038/s41581-019-0189-5

    Article  PubMed  Google Scholar 

  2. Heine GH (2015) Mineral metabolism in heart disease. Curr Opin Nephrol Hypertens 24(4):310–316

    CAS  PubMed  Google Scholar 

  3. Pickering JW, Endre ZH (2012) New metrics for assessing diagnostic potential of candidate biomarkers. Clin J Am Soc Nephrol 7(8):1355–1364

    Article  Google Scholar 

  4. Fassett RG, Venuthurupalli SK, Gobe GC, Coombes JS, Cooper MA, Hoy WE (2011) Biomarkers in chronic kidney disease: a review. Kidney Int 80(8):806–821

    Article  CAS  Google Scholar 

  5. Isakova T, Xie H, Yang W (2011) Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 305(23):2432–2439. https://doi.org/10.1001/jama.2011.826

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik II (Nephrologie, Hochdruck- und Gefäßkrankheiten), Agaplesion Markus Krankenhaus, Wilhelm-Epstein-Str. 4, 60431, Frankfurt am Main, Deutschland

    P. Diefenhardt & G. H. Heine

  2. University of Otago, Christchurch, Neuseeland

    J. W. Pickering

  3. Medizinische Fakultät, Universität des Saarlandes, Homburg, Deutschland

    G. H. Heine

Authors
  1. P. Diefenhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. W. Pickering
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. H. Heine
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Diefenhardt.

Ethics declarations

Interessenkonflikt

P. Diefenhardt, J. W. Pickering und G. H. Heine geben an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

T. Feldkamp, Kiel

J. Lutz, Mainz

L.T. Weber, Köln

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Diefenhardt, P., Pickering, J.W. & Heine, G.H. Erlaubt eine Bestimmung von FGF23 bei chronisch nierenkranken Menschen eine verbesserte Vorhersage renaler und kardiovaskulärer Ereignisse?. Nephrologe 15, 112–113 (2020). https://doi.org/10.1007/s11560-019-00399-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11560-019-00399-1

Search

Navigation